Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Research on Forest Laboratories and Cephalon -- Generic Drugs Making Great Strides
August 06, 2010
from Marketwired News Releases
Cephalon Reports Record Sales and Earnings in Second Quarter 2010
July 27, 2010
Quarterly Sales of $712 Million Increased 32 Percent Read More
from PR Newswire
Cephalon Expects Second Quarter 2010 Results to Exceed Previously Issued Guidance
July 21, 2010
from PR Newswire
TARIS Appoints Sarma Duddu as President and CEO
July 19, 2010
from Business Wire News Releases
Cephalon Second Quarter 2010 Earnings Conference Call Tuesday, July 27, 2010 at 5:00 p.m. EDT
June 24, 2010
from PR Newswire
Cephalon Partners with American Chronic Pain Association and the American Pharmacists Association to Expand National Initiative On the Safe and Appropriate Use of Prescription Medicines
June 23, 2010
Patients to Receive Educational Information at Pharmacies and Online Read More
from PR Newswire
Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
June 21, 2010
from PR Newswire
Cephalon Provides Clinical Update on Phase II Study of NUVIGIL as an Adjunctive Therapy in Adults with Schizophrenia
June 02, 2010
from PR Newswire
Strategos/wRatings Innovation Index Identifies the Most Innovative Pharmaceutical and Medical Device Companies
May 11, 2010
Pharmaceutical and Medical Device Companies Lag in Innovation Relative to Other Industries Read More
from Business Wire News Releases
Cephalon off to Record Start in 2010
May 04, 2010
Quarterly Sales of $577 Million Increased 12 Percent Read More
from PR Newswire
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
April 09, 2010
Acquisition Diversifies Global Pharmaceutical Business and Expands Presence in Western and Central Europe, Africa, and Middle East Territories Read More
from PR Newswire
Cephalon Completes Acquisition of Ception Therapeutics
April 05, 2010
Acquisition Adds Biologics Asset for Advancement to Phase Three Development Read More
from PR Newswire
Cephalon First Quarter 2010 Earnings Conference Call Tuesday, May 4, 2010 at 5:00 p.m. EDT
March 31, 2010
from PR Newswire
Wall Street News Alert: Breaking News: UYMG - March 30, 2010
March 30, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding Read More
from Marketwired News Releases
Critical Alerts for Apple, Boeing, EOG Resources, Cephalon, and Talbots Released by Seven Summits Research
March 30, 2010
from PR Newswire
Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
March 29, 2010
from PR Newswire
Wall Street News Alert: Trade Alert: Caleco Pharma Corp. -- February 24, 2010
February 24, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding Read More
from Marketwired News Releases
Cephalon Exercises its Option to Acquire Ception Therapeutics
February 23, 2010
Ception Delivers Positive Results from a Phase II Study of CINQUIL in Adult Eosinophilic Asthma Read More
from PR Newswire
Cephalon Reports Record Sales and Adjusted Net Income for 2009
February 11, 2010
Sales Exceed $2 Billion, Increasing for Tenth Year in a Row Read More
from PR Newswire
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
February 01, 2010
Expands Range of Products and Reach in Europe, Africa, and the Middle East Read More
from PR Newswire
Cephalon Announces Executive Leadership Changes
January 28, 2010
from PR Newswire
Critical Alerts for Chevron, BHP Billiton, FedEx, Cephalon, and Legg Mason Released By Seven Summits Research
January 21, 2010
from PR Newswire
Wall Street News Alert: Breaking News: Spine Pain Management -- January 21, 2010
January 21, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Cephalon Fourth Quarter & Full Year 2009 Earnings Conference Call Thursday, February 11, 2010 at 5:00 p.m. EST
January 08, 2010
from PR Newswire
Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
January 08, 2010
from PR Newswire
Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
December 21, 2009
Company Expects FDA Decision by End of First Quarter 2010 Read More
from PR Newswire
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
December 11, 2009
from PR Newswire
Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
December 02, 2009
from PR Newswire
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
November 23, 2009
from PR Newswire
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
November 05, 2009
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here